Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity

Overview of attention for article published in Gene Therapy, March 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

patent: 8 patents

Readers on

mendeley: 77 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

Delivery of oncolytic viruses using dendritic cells

Grant US-12606796-B2

United States of America

21 Apr 2026

CELL-BASED VEHICLES FOR POTENTIATION OF VIRAL THERAPY

Application EP-4371565-A1

European Patent Office

22 May 2024

Enhanced systems for cell-mediated oncolytic viral therapy

Grant US-11655455-B2

United States of America

23 May 2023

Cell-based vehicles for potentiation of viral therapy

Grant US-11505782-B2

United States of America

22 Nov 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.